Drug-eluting metallic stents in urology
Drugeluting metal stents (DESs) have been extensively used in coronary and vascular disease. This type of stents has been proven to provide significantly lower restenosis rates due to the reduction of neo-intimal hyperplasia in comparison to the traditionally used bare metal stents (BMSs). The latte...
Main Authors: | Panagiotis S Kallidonis, Ioannis S Georgiopoulos, Iason D Kyriazis, Abdulrahman M Al-Aown, Evangelos N Liatsikos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Indian Journal of Urology |
Subjects: | |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2014;volume=30;issue=1;spage=8;epage=12;aulast=Kallidonis |
Similar Items
-
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01) -
The full metallic double-pigtail ureteral stent: Review of the clinical outcome and current status
by: Panagiotis S Kallidonis, et al.
Published: (2015-01-01) -
Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
by: Maeng Michael, et al.
Published: (2012-10-01) -
First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
by: Raban Jeger, et al.
Published: (2016-11-01) -
Comparison of 3-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® zotarolimus-eluting stents in an Asian population
by: Yong Hoon Kim, et al.
Published: (2020-04-01)